Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02649296
Other study ID # Skanlab
Secondary ID
Status Recruiting
Phase N/A
First received October 29, 2015
Last updated September 27, 2016
Start date October 2015
Est. completion date December 2016

Study information

Verified date September 2016
Source Oslo and Akershus University College of Applied Sciences
Contact Hilde Sylliaas, Ass prof
Email hilde.sylliaas@hioa.no
Is FDA regulated No
Health authority Norway: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose is to find out the effect of Skanlab at knee arthrosis.


Description:

The patients diagnosed with knee arthrosis will be treated With Skanlab twice a week for four weeks.


Recruitment information / eligibility

Status Recruiting
Enrollment 16
Est. completion date December 2016
Est. primary completion date January 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 45 Years to 70 Years
Eligibility Inclusion Criteria:

- knee arthrosis in one or both legs

Exclusion Criteria:

- Pacemaker

- infusion pump

- cancer

- diabetes

- pregnancy

- blood clots

- bacteriological inflammation

- reduced sensitivity in the treatment area.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor)


Related Conditions & MeSH terms


Intervention

Other:
Skanlab bodywave
The intervention will be done twice a week

Locations

Country Name City State
Norway Oslo and Akershus University college of applied science Oslo

Sponsors (1)

Lead Sponsor Collaborator
Oslo and Akershus University College of Applied Sciences

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Knee injury and Osteoarthritis Outcome Score (KOOS) changes in pain 15 months No
See also
  Status Clinical Trial Phase
Terminated NCT01474031 - Prospective Study Deltamotion - DAA THA Study
Completed NCT00373971 - Preventing Loss of Weight, Fat Free Mass and Activities of Daily Living N/A
Recruiting NCT05483387 - Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments. Phase 4
Completed NCT02697955 - The Effect of Subsartorial Saphenous Block on Postoperative Pain Following Major Ankle and Hind Foot Surgery Phase 4
Completed NCT02323373 - Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty Phase 2
Recruiting NCT05077410 - Minimal Invasive TLIF Arthrodesis Using Augmented Reality Navigation for Percutaneous Pedicle Aiming
Recruiting NCT05460715 - The Medacta Quadra-P Anteverted Study
Recruiting NCT02748408 - The Medacta International SMS Post-Marketing Surveillance Study
Recruiting NCT05887284 - Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoarthritis N/A
Recruiting NCT06235710 - Prevalence of Musculoskeletal Complaints in Nursing Home Residents
Completed NCT04056234 - Study of the Articular Microbiota in Rheumatoid Arthritis.
Completed NCT02336932 - Vitamin D and the Free Hormone Hypothesis
Recruiting NCT05501743 - Evaluation of the Efficacy of an Intra-articular Injection of Autologous Microfat Combined With Autologous Platelet-enriched Plasma in the Treatment of Radiocarpal Osteoarthritis: a Randomized Controlled Non-inferiority Trial Versus Total Wrist Denervation (Established Standard Treatment). Phase 2
Completed NCT02510924 - Role of Airtraq Mobile to Improve Intubation Conditions With Airtraq N/A
Active, not recruiting NCT04997005 - The Medacta International AMIStem-P Post-Marketing Surveillance Study
Not yet recruiting NCT05314387 - S-11 SMR TT Hybrid Glenoid and Cementless Finned Short Stem
No longer available NCT02434913 - HUD: PIP Joint Implant N/A